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Triglyceride hydrolysis by cytosolic and lysosomal lipases mobilizes fatty acids from lipid droplet stores.
Kaushik and Cuervo (2015) found that chaperone-mediated autophagy removes the protective barrier from
the lipid droplet surface, facilitating lipolysis by cytosolic lipases and assembly of autolipophagosomes for
subsequent lysosomal lipid degradation.Intracellular lipolysis is the central
biochemical pathway to hydrolyze triglyc-
erides (TGs) to fatty acids (FAs) and glyc-
erol. FAs are essential precursors for
the synthesis of membrane lipids, act as
signaling molecules, are used for post-
translational modifications of proteins, or
are oxidized as energy-rich substrates
for ATP synthesis. Intracellular lipolysis
comes in two flavors: ‘‘neutral’’ lipolysis
is responsible for the degradation of
TGs stored in cytoplasmic lipid droplets
(LDs) and requires the activity of at least
three hydrolases (lipases), and ‘‘acid’’
lipolysis occurs in lysosomes, is respon-
sible for the catabolism of TGs delivered
via the uptake of TG-rich lipoproteins,
and involves lysosomal acid lipase
(LAL). For long, these processes were
considered straightforward and distinct.
However, research in the last decade
indicated that the cytosolic fat-degrading
machinery (lipolysome) is much more
elaborate than originally anticipated
(Zechner et al., 2012). Additionally, the
observation that LD-associated TGs are
subject to macrolipophagy showed that
‘‘acid’’ lysosomal lipolysis contributes
to degradation of cytosolic fat stores,
at least under prolonged fasting condi-
tions (Singh et al., 2009). Whether and
how these processes are coordinated
and if upstream regulatory mechanisms
exist to orchestrate both systems re-
mained elusive.
A recent study (Kaushik and Cuervo,
2015) now provides compelling evidence
for a new mechanism by which chap-
erone-mediated autophagy (CMA) affects
both pathways of TG breakdown, cyto-
plasmic neutral lipolysis and the mac-60 Cell Metabolism 22, July 7, 2015 ª2015 Erolipophagy-mediated lysosomal acid
lipolysis.
During CMA (a specialized form of
autophagy), heat shock cognate protein
of 70 kDa (hsc70) binds to specific
client proteins and chaperones them to
lysosomes, where lysosome-associated
membrane protein 2A (LAMP2A; L2A)
binds the complex for subsequent lyso-
somal uptake and degradation (Cuervo
and Wong, 2014). Paralleled by an induc-
tion of lipolysis, CMA increases in mice
fasted for 8–10 hr and persists during
3daysof starvation. L2Aknockoutanimals
(unable to degrade hsc70 client proteins)
develop severe hepatosteatosis due to
increased lipogenesis, reduced VLDL
secretion, and reduced FA oxidation
(Schneider et al., 2014). Increased hepatic
fat accumulation was partially explained
by defective CMA-mediated degradation
of enzymes involved in lipid binding, trans-
port, and synthesis in L2A-deficient
animals.
Kaushik and Cuervo demonstrate that
defective CMA also affects the catabolic
branch of lipid metabolism by inhibiting
both adipose triglyceride lipase (ATGL)-
mediated neutral lipolysis and macroli-
pophagy-mediated lysosomal lipolysis.
The actual mechanism involves the
degradation of the LD-associated pro-
teins perilipin 2 and 3 (PLIN2 and PLIN3)
by CMA. PLINs comprise a family of four
closely related proteins (PLIN1, 2, 3,
and 5) with different tissue expression
profiles. PLIN2 and 3 are ubiquitously ex-
pressed, with highest expression levels
in liver and small intestine, respectively.
PLINs serve several functions in lipolysis.
PLIN1, PLIN2, and PLIN5 shield LDs fromlsevier Inc.unrestrained access of lipases. Addition-
ally, at least PLIN1 and PLIN5 actively
participate in the recruitment and activa-
tion of lipases. Whether PLINs block or
activate lipolysis depends on their phos-
phorylation state in response to hormonal
(e.g., PKA-mediated) stimulation (Granne-
man andMoore, 2008; Pollak et al., 2015).
Kaushik and Cuervo show that CMA
regulates the abundance of PLIN2 and
PLIN3 on LDs. Inhibition of CMA-medi-
ated lysosomal proteolysis increases
protein levels of PLIN2 and PLIN3 on
LDs, while activation of CMA reduced
LD-associated PLIN2 levels. Both PLIN2
and PLIN3 contain the characteristic
penta-peptide motif necessary for hsc70
recognition and physically bind hsc70 on
LDs. In contrast, a variant of PLIN2
harboring an inactivating mutation in the
penta-peptide (mutPLIN2) cannot bind
hsc70 and therefore is not subjected
to lysosomal degradation. The resulting
increase of mutPLIN2 on LDs leads to
accumulation of larger LDs in cells. Inhibi-
tion of CMA also reduces the previously
observed proteasomal degradation of
PLIN2 (Xu et al., 2006) by a currently un-
known mechanism. The modulation of
PLIN protein abundance on LDs by CMA
directly affects both branches of lipolysis.
(1) The removal of PLIN2 by activated
CMA leads to increased presence of
ATGL on LDs, increased interaction with
its coactivator comparative gene iden-
tification-58 (CGI-58), and decreased
interaction with its inhibitor G0S2.
Conversely, increased PLIN2 on LDs in
CMA-defective L2A-deficient cells is
accompanied by a reduced presence of
ATGL and CGI-58 on LDs. (2) Additionally,
Figure 1. Chaperone-Mediated Autophagy Facilitates Lipolysis on PLIN2/PLIN3-Coated
Lipid Droplets
In the fed state, perilipins coat the entire lipid droplet (LD) and prevent the binding of cytosolic lipase
(ATGL), its coactivator CGI-58, andmacroautophagy proteins (ATGs). Upon fasting, chaperone-mediated
autophagy (CMA) is activated, leading to the binding of heat shock cognate protein of 70 kDa (hsc70) to
PLIN2 and PLIN3, assigning them for lysosome-associated membrane protein 2A (L2A)-dependent lyso-
somal degradation. Subsequently, ATGL and ATGs can access the LD and initiate the mobilization of fatty
acids (FAs) that are targeted to oxidation and ATP synthesis in the mitochondria.
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leads to decreased macrolipophagy due
to decreased binding of protein compo-
nents assembling the macroautophagy
complex. Accumulation of mutPLIN2
in CMA competent cells also decreases
autolipophagosome formation, arguing
for an inhibitory role of PLIN2 in
macrolipophagy.
Collectively, Kaushik and Cuervo
present a new regulatory mechanism
upstream of both cytoplasmic and lyso-
somal lipolysis (summarized in Figure 1).
This discovery is very exciting, but also
leaves us with many questions that need
to be addressed in future studies. For
example, it remains unclear why CMA
does not remove the entire PLIN2 fromLDs but acts punctually at very discrete
locations. Is it possible that the hsc70
recognition motif in PLIN2 is masked by
protein-folding or protein-protein interac-
tions and needs to be exposed in order
to mark the protein for degradation?
As PLIN2 is a phosphoprotein (Bartz
et al., 2007) and binds CGI-58 (Yamaguchi
et al., 2006), one may speculate that
changes in the phosphorylation pattern
mask or unmask the recognition motif for
hsc70bindingand lysosomaldegradation.
Additional questions that arise relate
to the cell and tissue specificity and a
potentially more general role for the pro-
cess: Do tissue-specific differences exist
in CMA-regulated lipolysis in white and
brown adipose tissue, cardiac muscleCell Metaboland skeletal muscle, liver, or macro-
phages, etc.? Are the effects of lipolysis
abolished in PLIN2 (or PLIN3) knockout
mice, or does CMA also regulate the
abundance and activity of other LD-asso-
ciated proteins and potent lipolytic regu-
lators such as PLIN1, PLIN5, CGI-58,
G0S2, Fsp27, and others? Does CMA
contribute to the action of numerous ef-
fectors of lipolysis including hormones,
cytokines, or drugs? As hepatic CMA
activity declines with prolonged high-fat/
high-cholesterol feeding or with age
(Cuervo andWong, 2014), it will be impor-
tant to clarify how CMA regulates lipolysis
in the pathogenesis of various metabolic
diseases, or during aging. Accordingly,
future studies are needed to evaluate
whether reduced CMA activity may
contribute to ectopic lipid accumulation
under these conditions by building a LD
barrier that protects the LD from lipolytic
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